Company or ticker...

Relay Therapeutics

Relay uses structural biology and computation to design precision cancer medicines.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

RLAY

3.8B

395.9

n/a

109.22%

Key Facts

M. Cap

PS

PE

YTD

3.8B

395.9

n/a

109.22%

10MA

20MA

50MA

200MA

$RLAY